AI-driven drug discovery: Exploring Abaucin as a promising treatment against multidrug-resistant .

Background And Aims: This study presents a comprehensive overview of a well-recognized critical pathogen and demonstrates the potential of artificial intelligence (AI) in discovering new antibiotics. It is well-known for causing serious infections, especially in patients admitted to intensive care units, which is further compromised by bacterium's resistance to even last-resort antibiotics like carbapenems, posing critical challenges in its treatment and eradication. This article discusses Abaucin, a revolutionary antibiotic created from artificial intelligence, as a creative and potential treatment for .